Drugs / BCG
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04073160 Background | Jun 2020 → Jul 2021 | urinary bladder cancer | Daniel George, MD | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG | “Intravesicular therapy will consist of BCG, gemcitabine, mitomycin or a similar drug, depending on institutional standards and treating provider's discretion.” NCT04073160 ↗ |
| Route | Other | “Intravesicular therapy will consist of BCG” NCT04073160 ↗ |